At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 64 enrolled
Drug / intervention
Seasonal Influenza Vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD® Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009, When Administered to Elderly Subjects
In Brief
A Phase 2 clinical trial evaluating Seasonal Influenza Vaccine for Interpandemic Influenza. Completed, enrolled 64 participants across 2 sites.
Detailed Summary
Trial for annual approval of interpandemic influenza vaccines
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInterpandemic Influenza
CountriesItaly
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2008
Primary CompletionJul 2008
First PostedAug 2008
TodayJul 2026
First PostedAug 14, 2008
Enrollment StartJun 1, 2008
Primary CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.9 years ago
Interventions
Seasonal Influenza Vaccinebiological
1 single intramuscular dose of influenza vaccine, 2008/2009 NH formulation